Orbimed Capital Llc - Net Worth and Insider Trading
Orbimed Capital Llc Net Worth
The estimated net worth of Orbimed Capital Llc is at least $197 Million dollars as of 2024-05-26. Orbimed Capital Llc is the 2102 Investment manager of CanSino Biologics Inc and owns about 8,918,200 shares of CanSino Biologics Inc (HKSE:06185) stock worth over $197 Million. Details can be seen in Orbimed Capital Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Orbimed Capital Llc has not made any transactions after 2019-03-28 and currently still holds the listed stock(s).
Transaction Summary of Orbimed Capital Llc
Orbimed Capital Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Orbimed Capital Llc owns 1 companies in total, including CanSino Biologics Inc (HKSE:06185) .
Click here to see the complete history of Orbimed Capital Llc’s form 4 insider trades.
Insider Ownership Summary of Orbimed Capital Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:06185 | CanSino Biologics Inc | 2019-03-28 | 2102 Investment manager |
Orbimed Capital Llc Latest Holdings Summary
Orbimed Capital Llc currently owns a total of 1 stock. Orbimed Capital Llc owns 8,918,200 shares of CanSino Biologics Inc (HKSE:06185) as of March 28, 2019, with a value of $197 Million.
Latest Holdings of Orbimed Capital Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:06185 | CanSino Biologics Inc | 2019-03-28 | 8,918,200 | 22.05 | 196,646,310 |
Holding Weightings of Orbimed Capital Llc
Orbimed Capital Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Orbimed Capital Llc has made a total of 0 transactions in CanSino Biologics Inc (HKSE:06185) over the past 5 years. The most-recent trade in CanSino Biologics Inc is the sale of 8,918,200 shares on March 28, 2019, which brought Orbimed Capital Llc around $0.
Insider Trading History of Orbimed Capital Llc
- 1
Orbimed Capital Llc Trading Performance
Orbimed Capital Llc Ownership Network
Orbimed Capital Llc Owned Company Details
What does CanSino Biologics Inc do?
Who are the key executives at CanSino Biologics Inc?
Orbimed Capital Llc is the 2102 Investment manager of CanSino Biologics Inc. Other key executives at CanSino Biologics Inc include 2201 Interest of corporation controlled by you The Capital Group Companies, Inc. , Jpmorgan Chase & Co. , and Citigroup Inc. .
CanSino Biologics Inc (HKSE:06185) Insider Trades Summary
Over the past 18 months, Orbimed Capital Llc made no insider transaction in CanSino Biologics Inc (HKSE:06185). Other recent insider transactions involving CanSino Biologics Inc (HKSE:06185) include a net sale of 2,597,999 shares made by Jpmorgan Chase & Co. , a net sale of 0 shares made by Citigroup Inc. , and a net sale of 7,656,500 shares made by The Capital Group Companies, Inc. .
In summary, during the past 3 months, insiders sold 0 shares of CanSino Biologics Inc (HKSE:06185) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 14,566,445 shares of CanSino Biologics Inc (HKSE:06185) were sold and 4,938,946 shares were bought by its insiders, resulting in a net sale of 9,627,499 shares.
CanSino Biologics Inc (HKSE:06185)'s detailed insider trading history can be found in Insider Trading Tracker table.
CanSino Biologics Inc Insider Transactions
Orbimed Capital Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Orbimed Capital Llc. Currently GuruFocus does not have mailing address information for Orbimed Capital Llc.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
